osteoprotection semaphorin 3a 
bony skeleton maintained local factors regulate bone-forming osteoblasts bone-resorbing osteoclasts addition hormonal activity osteoprotegerin protects bone inhibiting osteoclastic bone resorption factor yet identified local determinant bone mass regulates osteoclasts osteoblasts show semaphorin 3a sema3a exerts osteoprotective effect suppressing osteoclastic bone resorption increasing osteoblastic bone formation binding sema3a neuropilin- nrp1 inhibited receptor activator nuclear factor-kappa b ligand rankl-induced osteoclast differentiation inhibiting immunoreceptor tyrosine-based activation motif itam rhoa signalling pathways addition sema3a nrp1 binding stimulated osteoblast inhibited adipocyte differentiation canonical wnt/beta-catenin signalling pathway osteopenic phenotype sema3a-/- mice recapitulated mice sema3a-binding site nrp1 genetically disrupted intravenous sema3a administration mice increased bone volume expedited bone regeneration thus sema3a promising new therapeutic agent bone joint diseases 
